Molecular Partners Ag (MOLN) Change in Receivables (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Change in Receivables of -$623.18 for Q1 2026, up 66.02% year-on-year from -$375.36 in Q1 2025, and down 100.1% on a QoQ basis from $606548.3 in Q4 2025.

Molecular Partners Ag (MOLN) Change in Receivables (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Change in Receivables for 7 consecutive years, with -$623.18 the latest figure, recorded in Q1 2026.

  • Quarterly Change in Receivables rose 66.02% year-over-year to -$623.18 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $662395.3 (up 301.33% YoY) and the FY2025 annual result came in at $606817.3, up 253.19% from the prior year.
  • Change in Receivables declined to -$623.18 in Q1 2026 per MOLN's latest filing, from $606548.3 in the prior quarter.
  • Over the last five years, Change in Receivables for MOLN reached as high as $26.2 million in Q4 2022 and fell as low as -$24.4 million in Q3 2022.
  • A 5-year average of $1.5 million and a median of -$766.54 in 2023 frame the typical range for Change in Receivables.
  • The largest YoY upside for Change in Receivables was 650.4% in 2022 against a maximum downside of 546.98% in 2022.
  • Year by year, Change in Receivables stood at $26.2 million in 2022, then slumped by 104.01% to -$1.1 million in 2023, then jumped by 62.46% to -$394569.3 in 2024, then soared by 253.72% to $606548.3 in 2025, then slumped by 100.1% to -$623.18 in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods registered -$623.18, $606548.3, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 75.30 Mn
4 NuCana 279.75 Bn 279.75 Bn - 2.84 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -39.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - -623.18

Historic Data

Download Data
DateValue
Mar 31, 2026 -623.18
Mar 31, 2026 -623.18
Dec 31, 2025 606,548.35
Dec 31, 2025 606,548.35
Sep 30, 2025 1.61 Mn
Sep 30, 2025 1.61 Mn
Jun 30, 2025 -1.55 Mn
Jun 30, 2025 -1.55 Mn
Mar 31, 2025 -1,834.10
Mar 31, 2025 -1,834.10
Dec 31, 2024 -394,569.31
Dec 31, 2024 -394,569.31
Sep 30, 2024 1.61 Mn
Sep 30, 2024 1.61 Mn
Jun 30, 2024 -1.54 Mn
Jun 30, 2024 -1.54 Mn
Mar 31, 2024 -1,364.51
Mar 31, 2024 -1,364.51
Dec 31, 2023 -1.05 Mn
Dec 31, 2023 -1.05 Mn